Sarcoma Classification by DNA Methylation Profiling

Sarcomas are malignant soft tissue and bone tumours affecting adults, adolescents and children. They represent a morphologically heterogeneous class of tumours and some entities lack defining histopathological features. Therefore, the diagnosis of sarcomas is burdened with a high inter-observer variability and misclassification rate. Here, we demonstrate classification of soft tissue and bone tumours using a machine learning classifier algorithm based on array-generated DNA methylation data. This sarcoma classifier is trained using a dataset of 1077 methylation profiles from comprehensively pre-characterized cases comprising 62 tumour methylation classes constituting a broad range of soft tissue and bone sarcoma subtypes across the entire age spectrum. The performance is validated in a cohort of 428 sarcomatous tumours, of which 322 cases were classified by the sarcoma classifier. Our results demonstrate the potential of the DNA methylation-based sarcoma classification for research and future diagnostic applications.

Citing Articles

Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modules.

Glaser S, Fischer A, Martinez-Manjon J, Lopez C, Kretzmer H, Burkhardt B Leukemia. 2025; .

PMID: 40065077 DOI: 10.1038/s41375-025-02533-6.

Rapid brain tumor classification from sparse epigenomic data.

Brandl B, Steiger M, Kubelt C, Rohrandt C, Zhu Z, Evers M Nat Med. 2025; .

PMID: 40021833 DOI: 10.1038/s41591-024-03435-3.

Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics.

Benfatto S, Sill M, Jones D, Pfister S, Sahm F, von Deimling A Nat Commun. 2025; 16(1):1787.

PMID: 39979307 PMC: 11842776. DOI: 10.1038/s41467-025-57078-0.

cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics.

Aldape K, Capper D, von Deimling A, Giannini C, Gilbert M, Hawkins C Neurooncol Adv. 2025; 7(1):vdae228.

PMID: 39902391 PMC: 11788596. DOI: 10.1093/noajnl/vdae228.

SMARCB1-deficient malignant melanocytic uveal tumours: a new neural crest-derived tumour entity with SMARCB1-related germline predisposition.

Cyrta J, Masliah-Planchon J, Hoare O, Brillet R, Andrianteranagna M, Sohier P J Pathol. 2025; 265(3):357-371.

PMID: 39853675 PMC: 11794973. DOI: 10.1002/path.6390.

References

Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

Weidema M, van de Geer E, Koelsche C, Desar I, Kemmeren P, Hillebrandt-Roeffen M . DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas. Clin Cancer Res. 2019; 26(1):93-100. DOI: 10.1158/1078-0432.CCR-19-2180. View

Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss D . Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol. 2018; 136(2):273-291. DOI: 10.1007/s00401-018-1837-8. View

Wu S, Cooper B, Bu F, Bowman C, Killian J, Serrano J . DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas. JCO Precis Oncol. 2018; 2017. PMC: 5772901. DOI: 10.1200/PO.17.00031. View

. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017; 171(4):950-965.e28. PMC: 5693358. DOI: 10.1016/j.cell.2017.10.014. View

Pajtler K, Witt H, Sill M, Jones D, Hovestadt V, Kratochwil F . Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell. 2015; 27(5):728-43. PMC: 4712639. DOI: 10.1016/j.ccell.2015.04.002. View

Worst B, van Tilburg C, Balasubramanian G, Fiesel P, Witt R, Freitag A . Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study. Eur J Cancer. 2016; 65:91-101. DOI: 10.1016/j.ejca.2016.06.009. View

Maros M, Capper D, Jones D, Hovestadt V, von Deimling A, Pfister S . Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data. Nat Protoc. 2020; 15(2):479-512. DOI: 10.1038/s41596-019-0251-6. View

Lokk K, Modhukur V, Rajashekar B, Martens K, Magi R, Kolde R . DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 2014; 15(4):r54. PMC: 4053947. DOI: 10.1186/gb-2014-15-4-r54. View

10.

Idbaih A, Coindre J, Derre J, Mariani O, Terrier P, Ranchere D . Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest. 2005; 85(2):176-81. DOI: 10.1038/labinvest.3700202. View

11.

Sahm F, Schrimpf D, Jones D, Meyer J, Kratz A, Reuss D . Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol. 2015; 131(6):903-10. DOI: 10.1007/s00401-015-1519-8. View

12.

Perrier L, Rascle P, Morelle M, Toulmonde M, Ranchere Vince D, Cesne A . The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group. PLoS One. 2018; 13(4):e0193330. PMC: 5886412. DOI: 10.1371/journal.pone.0193330. View

13.

Capper D, Stichel D, Sahm F, Jones D, Schrimpf D, Sill M . Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018; 136(2):181-210. PMC: 6060790. DOI: 10.1007/s00401-018-1879-y. View

14.

Hovestadt V, Jones D, Picelli S, Wang W, Kool M, Northcott P . Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature. 2014; 510(7506):537-41. DOI: 10.1038/nature13268. View

15.

Sturm D, Orr B, Toprak U, Hovestadt V, Jones D, Capper D . New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016; 164(5):1060-1072. PMC: 5139621. DOI: 10.1016/j.cell.2016.01.015. View

16.

Rohrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A . Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol. 2016; 131(6):877-87. DOI: 10.1007/s00401-016-1540-6. View

17.

Selt F, Deiss A, Korshunov A, Capper D, Witt H, van Tilburg C . Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors. Brain Pathol. 2015; 26(4):506-16. PMC: 8029243. DOI: 10.1111/bpa.12326. View

18.

Koelsche C, Mynarek M, Schrimpf D, Bertero L, Serrano J, Sahm F . Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations. Acta Neuropathol. 2018; 136(2):327-337. DOI: 10.1007/s00401-018-1871-6. View

19.

Italiano A, Di Mauro I, Rapp J, Pierron G, Auger N, Alberti L . Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. Lancet Oncol. 2016; 17(4):532-538. DOI: 10.1016/S1470-2045(15)00583-5. View

20.

Hovestadt V, Remke M, Kool M, Pietsch T, Northcott P, Fischer R . Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 2013; 125(6):913-6. PMC: 3661908. DOI: 10.1007/s00401-013-1126-5. View